Prenatal Imaging and Intervention


Overview

Fetal genitourinary system abnormalities encompass a wide spectrum of disorders varying in degrees of severity and include developmental anomalies, obstructive lesions in the urinary tract, and renal parenchymal diseases. The prenatal evaluation of the genitourinary system includes assessment of the amniotic fluid, the kidneys, the bladder, and associated anomalies. Amniotic fluid is important for normal fetal development, particularly the fetal lungs. In the first trimester, amniotic fluid forms as a dialysate of maternal serum. Fetal urine production begins by 12 weeks of gestation and becomes the major source of amniotic fluid by 16 weeks. Fetal urine production is typically 120 mL/day at 20 weeks and increases gradually to 1200 mL/day by term. The fetus voids every 30 to 60 minutes. The bladder should be visualized at least once during a prenatal imaging examination.

Identification of the fetal urinary bladder is attempted in the first trimester ultrasound, and more detailed evaluation of the kidneys and bladder is a fundamental part of the second trimester fetal anatomic assessment. Complex cases, such as bladder exstrophy, confusing duplex collecting systems, and obstructive masses, may be further evaluated by fetal magnetic resonance imaging (MRI). Sonographic fetal anatomic assessment may be limited in the setting of oligohydramnios, and MRI may be particularly useful. Prenatal findings may influence the further pursuit of genetic and laboratory testing or surgical intervention and may guide the delivery plan.

Normal Fetal Genitourinary Tract

Overview and Imaging.

Fetal kidneys can be identified at 13 weeks of gestation. Normal renal sizes through gestation (mean kidney length in millimeters is slightly longer than weeks of gestation) are shown in Table 112.1 . Corticomedullary differentiation is apparent by 20 weeks of gestation ( Fig. 112.1 ). Renal calyces and ureters typically are not seen on ultrasound unless they are pathologically dilated, and the renal pelvis is only readily visualized once the anterior-posterior diameter exceeds 2 mm. The fetal bladder can be visualized at 10 weeks of gestation. The bladder wall should not measure more than 3 mm. Bladder wall thickening may be a sign of outlet obstruction.

TABLE 112.1
Normal Fetal Renal Lengths
Modified from Cohen HL, Cooper J, Eisenberg P, et al. Normal length of fetal kidneys. Am J Roentgenol. 1991;157:545–548.
Gestational Age (wk) Mean Kidney Length (cm) 95% Confidence Interval (cm)
18 2.2 1.6-2.8
19 2.3 1.5-3.1
20 2.6 1.8-3.4
21 2.7 2.1-3.2
22 2.7 2-3.4
23 3 2.2-3.7
24 3.1 1.9-4.4
25 3.3 2.5-4.2
26 3.4 2.4-4.4
27 3.5 2.7-4.4
28 3.4 2.6-4.2
29 3.6 2.3-4.8
30 3.8 3.9-4.6
31 3.7 2.8-4.6
32 4.1 3.1-5.1
33 4 3.3-4.7
34 4.2 3.3-5
35 4.2 3.2-5.2
36 4.2 3.3-5
37 4.2 3.3-5.1
38 4.4 3.2-5.6
39 4.2 3.5-4.8
40 4.3 3.2-5.3
41 4.5 3.9-5.1

Figure 112.1, Normal fetal kidneys.

Amniotic fluid volume can be a reflection of renal health. Oligohydramnios (defined by an amniotic fluid index less than 8 cm) may be seen in the setting of placental insufficiency, intrauterine growth retardation, chromosomal abnormality, premature rupture of membranes, post-dates gestation, or urologic pathology ( Box 112.1 ).

Box 112.1
Renal Etiologies for Oligohydramnios

  • Bilateral renal agenesis

  • Bilateral multicystic dysplastic kidney

  • Bilateral severe ureteropelvic junction obstruction

  • Bilateral renal disease with one kidney each involved with items 1, 2, or 3 above

  • Severe prune-belly syndrome

  • Severe autosomal recessive polycystic kidney disease

  • Severe renal dysplasia as a result of posterior urethral valves or urethral atresia

Renal Parenchymal Disorders

Overview.

Fetal renal echogenicity may be abnormally increased as a normal variant but more often reflects an underlying abnormality. The fetal kidney is considered echogenic if it is brighter than the fetal liver. Echogenic kidneys are observed in approximately 1 to 2 per 1000 fetal ultrasounds, and approximately 10% of cases of renal malformations include echogenic kidneys. Etiologic considerations for the echogenic kidney are summarized in Box 112.2 . If echogenic kidneys are identified and the amniotic fluid volume is normal, the findings suggest nonlethal renal disease. Echogenic kidneys with oligohydramnios are highly concerning for a poor outcome.

Box 112.2
Causes of Fetal Echogenic Kidney

  • Idiopathic

  • Cystic renal disease

  • Infection

  • Chromosomal abnormalities

  • Toxic and ischemic insults

Cystic Renal Disease

Overview.

Congenital cystic renal diseases occur in about 2 to 4 in 1000 live births and include autosomal dominant and autosomal recessive polycystic kidney disease ( Fig. 112.2 and ), multicystic dysplastic kidney ( Fig. 112.3 ), cystic glomerulopathies, and other cystic renal dysplasias. The complex pathogenesis of these disorders involves an abnormal orchestration of transcription and growth factor expression ( Table 112.2 ), as well as ciliopathies affecting the renal tubule primary cilium ( Table 112.3 ). Structural and functional abnormalities in primary cilia contribute to various cystic phenotypes that involve the kidney and liver.

Figure 112.2, Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD).

Figure 112.3, Multicystic dysplastic kidney.

TABLE 112.2
Selected Examples of Gene Mutations Resulting in Congenital Urinary Tract Abnormalities
Modified from Bonsib SM. The classification of renal cystic diseases and other congenital malformations of the kidney and urinary tract. Arch Pathol Lab Med. 2010;134(4):554–568.
Renal Abnormality PAX2 (paired box 2 gene, 10q24.31) HNF1B (HNF1B Homeobox B, 17q12) EYA1 (EYA transcriptional coactivator and phosphatase 1 gene, 8q13.3) SIX1 (SIX Homeobox 1, 14q23.1) SALL1 (Spalt like transcription factor 1, 16q12.1) GATA3 (GATA binding protein 3 gene, 10p14)
Dysplasia
Renal agenesis
Renal hypoplasia
Ureteropelvic junction obstruction
Vesicoureteral reflux
Glomerulocystic kidney disease
Syndrome Renal-coloboma MODY5 BOR BOR Townes-Brock HDR
BOR, Brachio-oto-renal; HDR, hypoparathyroidism, deafness, and renal dysplasia; MODY5, maturity-onset diabetes, type 5.

TABLE 112.3
Ciliopathies: Molecular, Genetic, and Pathologic Features
Modified from Bonsib SM. The classification of renal cystic diseases and other congenital malformations of the kidney and urinary tract. Arch Pathol Lab Med. 2010;134(4):554–568.
Ciliopathy Protein Inheritance Lesions
Autosomal dominant PKD Polycystin 1, Polycystin 2 AD Cysts within the entire nephron
Autosomal recessive PKD Fibrocystin AR Collecting duct cysts
Meckel-Gruber syndrome MKS proteins 1, 3 AR Cystic dysplasia
Oral-facial-digital syndrome OFD protein X-linked Glomerular kidney disease
Bardet-Beidl syndrome BBS proteins 1-8 Digenic Tubulointerstitial nephritis
Von Hippel-Lindau VHL protein AR Renal cysts (premalignant) and renal cell carcinoma
AD, Autosomal dominant; AR, autosomal recessive; PKD, polycystic kidney disease.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here